Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 10,501 shares at $94.26 ($1.0M) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Seasonal sale ($1.0M) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.26 | 1,648 | $155K | 15.2% |
| 2 | $95.41 | 148 | $14K | 1.4% |
| 3 | $96.90 | 1,525 | $148K | 14.4% |
| 4 | $98.27 | 4,141 | $407K | 39.7% |
| 5 | $99.00 | 3,039 | $301K | 29.4% |
| Total | $97.61 avg | 10,501 |
| $1.0M |
| 100% |
| Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |
| WGS | SELL | 2026-03-30 | $5.9M | — | Filing → |